Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies.

作者: Hong Zhu , Elizabeth Mathew , Sara M. Connelly , Jeffrey Zuber , Mark Sullivan

DOI: 10.1371/JOURNAL.PONE.0221550

关键词:

摘要: HIV envelope protein (Env) is the sole target of broadly neutralizing antibodies (BNAbs) that are capable diverse strains HIV. While BNAbs develop spontaneously in a subset HIV-infected patients, efforts to design an protein-based immunogen elicit antibody responses have so far been unsuccessful. It hypothesized primary barrier eliciting fact proteins bind poorly germline-encoded unmutated common ancestor (UCA) precursors BNAbs. To identify variant forms Env with increased affinities for UCA 4E10 and 10E8, which Membrane Proximal External Region (MPER) Env, libraries randomly mutated variants were expressed yeast surface display system screened using fluorescence activated cell sorting cells displaying enhanced abilities antibodies. Based on analyses individual clones obtained from screen next-generation sequencing sorted libraries, distinct but partially overlapping sets amino acid substitutions conferring binding identified. These particularly enriched arginine highly conserved tryptophan residues. The UCA-binding also generally exhibited mature anti-MPER Mapping identified into available structures suggest they may act by destabilizing both initial pre-fusion conformation six-helix bundle involved fusion viral membranes, as well providing new or expanded epitopes accessibility

参考文章(87)
Bryan Briney, Devin Sok, Joseph G. Jardine, Daniel W. Kulp, Patrick Skog, Sergey Menis, Ronald Jacak, Oleksandr Kalyuzhniy, Natalia de Val, Fabian Sesterhenn, Khoa M. Le, Alejandra Ramos, Meaghan Jones, Karen L. Saye-Francisco, Tanya R. Blane, Skye Spencer, Erik Georgeson, Xiaozhen Hu, Gabriel Ozorowski, Yumiko Adachi, Michael Kubitz, Anita Sarkar, Ian A. Wilson, Andrew B. Ward, David Nemazee, Dennis R. Burton, William R. Schief, Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies Cell. ,vol. 166, pp. 1459- 1470 ,(2016) , 10.1016/J.CELL.2016.08.005
Amelia Escolano, Jon M. Steichen, Pia Dosenovic, Daniel W. Kulp, Jovana Golijanin, Devin Sok, Natalia T. Freund, Alexander D. Gitlin, Thiago Oliveira, Tatsuya Araki, Sarina Lowe, Spencer T. Chen, Jennifer Heinemann, Kai-Hui Yao, Erik Georgeson, Karen L. Saye-Francisco, Anna Gazumyan, Yumiko Adachi, Michael Kubitz, Dennis R. Burton, William R. Schief, Michel C. Nussenzweig, Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice Cell. ,vol. 166, pp. 1445- 1458 ,(2016) , 10.1016/J.CELL.2016.07.030
Jon M. Steichen, Daniel W. Kulp, Talar Tokatlian, Amelia Escolano, Pia Dosenovic, Robyn L. Stanfield, Laura E. McCoy, Gabriel Ozorowski, Xiaozhen Hu, Oleksandr Kalyuzhniy, Bryan Briney, Torben Schiffner, Fernando Garces, Natalia T. Freund, Alexander D. Gitlin, Sergey Menis, Erik Georgeson, Michael Kubitz, Yumiko Adachi, Meaghan Jones, Andrew A. Mutafyan, Dong Soo Yun, Christian T. Mayer, Andrew B. Ward, Dennis R. Burton, Ian A. Wilson, Darrell J. Irvine, Michel C. Nussenzweig, William R. Schief, HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies Immunity. ,vol. 45, pp. 483- 496 ,(2016) , 10.1016/J.IMMUNI.2016.08.016
LaTonya D. Williams, Gilad Ofek, Sebastian Schätzle, Jonathan R. McDaniel, Xiaozhi Lu, Nathan I. Nicely, Liming Wu, Caleb S. Lougheed, Todd Bradley, Mark K. Louder, Krisha McKee, Robert T. Bailer, Sijy O’Dell, Ivelin S. Georgiev, Michael S. Seaman, Robert J. Parks, Dawn J. Marshall, Kara Anasti, Guang Yang, Xiaoyan Nie, Nancy L. Tumba, Kevin Wiehe, Kshitij Wagh, Bette Korber, Thomas B. Kepler, S. Munir Alam, Lynn Morris, Gift Kamanga, Myron S. Cohen, Mattia Bonsignori, Shi-Mao Xia, David C. Montefiori, Garnett Kelsoe, Feng Gao, John R. Mascola, M. Anthony Moody, Kevin O. Saunders, Hua-Xin Liao, Georgia D. Tomaras, George Georgiou, Barton F. Haynes, Potent and broad HIV-neutralizing antibodies in memory B cells and plasma. Science immunology. ,vol. 2, ,(2017) , 10.1126/SCIIMMUNOL.AAL2200
Garnett Kelsoe, Barton F. Haynes, Host controls of HIV broadly neutralizing antibody development. Immunological Reviews. ,vol. 275, pp. 79- 88 ,(2017) , 10.1111/IMR.12508
Adriana Irimia, Andreia M. Serra, Anita Sarkar, Ronald Jacak, Oleksandr Kalyuzhniy, Devin Sok, Karen L. Saye-Francisco, Torben Schiffner, Ryan Tingle, Michael Kubitz, Yumiko Adachi, Robyn L. Stanfield, Marc C. Deller, Dennis R. Burton, William R. Schief, Ian A. Wilson, Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design. PLOS Pathogens. ,vol. 13, ,(2017) , 10.1371/JOURNAL.PPAT.1006212
Saikat Banerjee, Heliang Shi, Marisa Banasik, Hojin Moon, William Lees, Yali Qin, Andrew Harley, Adrian Shepherd, Michael W. Cho, Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region. Virology. ,vol. 505, pp. 113- 126 ,(2017) , 10.1016/J.VIROL.2017.02.015
Thomas H. King, Crystal A. Shanley, Zhimin Guo, Donald Bellgrau, Timothy Rodell, Synthia Furney, Marcela Henao-Tamayo, Ian M. Orme, GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis Clinical and Vaccine Immunology. ,vol. 24, ,(2017) , 10.1128/CVI.00245-17
S Anthony, MD Fauci, An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic. JAMA. ,vol. 318, pp. 1535- 1536 ,(2017) , 10.1001/JAMA.2017.13505
Yong Gao, Paul McKay, Jamie Mann, Advances in HIV-1 Vaccine Development. Viruses. ,vol. 10, pp. 167- ,(2018) , 10.3390/V10040167